KOC
AZN icon

Koss-Olinger Consulting’s AstraZeneca AZN Stock Holding History

Koss-Olinger Consulting’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,409
Closed -$320K – 189
2022
Q1 		$320K Sell
2,409
-1,318
-35% -$158K 0.05% 144
2021
Q4 		$434K Sell
3,727
-748
-17% -$88K 0.07% 124
2021
Q3 		$537K Sell
4,475
-1,739
-28% -$202K 0.09% 107
2021
Q2 		$744K Buy
6,214
+531
+9% +$58.3K 0.11% 106
2021
Q1 		$565K Buy
+5,683
New +$571K 0.1% 114

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Koss-Olinger Consulting's AZN Position: Q2 2022 in Review

Koss-Olinger Consulting sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 2,409 shares — an estimated $320K sold.

Koss-Olinger Consulting first reported a position in AZN in Q1 2021 and held it in 5 quarters. The position peaked at $744K in Q2 2021. 1,015 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

  • Koss-Olinger Consulting reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
  • Koss-Olinger Consulting sold 2,409 AstraZeneca shares in Q2 2022, an estimated $320K.
  • Koss-Olinger Consulting first reported a position in AstraZeneca in Q1 2021 and held it in 5 quarters.
  • Koss-Olinger Consulting's AstraZeneca position peaked at $744K in Q2 2021.
  • 1,015 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on Koss-Olinger Consulting's 13F filing for Q2 2022, filed 8 Jul 2022.